Skip to main content
PMC home page
Annals of The Royal College of Surgeons of England logoLink to Annals of The Royal College of Surgeons of England
. 1991 Mar;73(2):96–99.

The activity of locally applied cytotoxics to breast cancer cells in vitro.

K G Park 1, U Chetty 1, W Scott 1, W Miller 1
PMCID: PMC2499370  PMID: 1708217

Abstract

The ability of commonly used operative lavage solutions to destroy breast cancer cells was investigated. The cytotoxicity of solutions of Savlon, noxythiolin, povidone iodine, hydrogen peroxide, bleomycin and water on two human breast cancer cell lines was measured in vitro. Viable cells were determined by ability to exclude trypan blue. Results have been analysed with standard non-parametric tests and demonstrate that all solutions tested significantly (P less than 0.01) reduced the number of viable cells recovered when compared with a control solution of phosphate buffered saline. Solutions of Savlon, 2.5% noxythiolin and povidone iodine were more effective than the other agents in reducing the number of recovered viable cells.

Full text

PDF
96

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Desai S., Jamieson C. W. Intraperitoneal noxytiolin as an experimental chemotherapeutic agent. Br J Surg. 1973 May;60(5):350–351. doi: 10.1002/bjs.1800600506. [DOI] [PubMed] [Google Scholar]
  2. Gibson G. R., Stephens F. O. Experimental use of cetrimide in the prevention of wound implantation with cancer cells. Lancet. 1966 Sep 24;2(7465):678–680. doi: 10.1016/s0140-6736(66)92834-0. [DOI] [PubMed] [Google Scholar]
  3. Gilmore O. J., Martin T. D., Fletcher B. N. Prevention of wound infection after appendicectomy. Lancet. 1973 Feb 3;1(7797):220–222. doi: 10.1016/s0140-6736(73)90063-9. [DOI] [PubMed] [Google Scholar]
  4. Iitsuka Y., Kaneshima S., Tanida O., Takeuchi T., Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer. 1979 Oct;44(4):1476–1480. doi: 10.1002/1097-0142(197910)44:4<1476::aid-cncr2820440442>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  5. KEYNES W. M. Implantation from the bowel lumen in cancer of the large intestine. Ann Surg. 1961 Mar;153:357–364. doi: 10.1097/00000658-196103000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. MORALES F., BELL M., MCDONALD G. O., COLE W. H. The prophylactic treatment of cancer at the time of operation. Ann Surg. 1957 Oct;146(4):588–595. doi: 10.1097/00000658-195710000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rosenberg I. L., Russell C. W., Giles G. R. Cell viability studies on the exfoliated colonic cancer cell. Br J Surg. 1978 Mar;65(3):188–190. doi: 10.1002/bjs.1800650314. [DOI] [PubMed] [Google Scholar]
  8. SMITH R. R., THOMAS L. B., HILBERG A. W. Cancer cell contamination of operative wounds. Cancer. 1958 Jan-Feb;11(1):53–62. doi: 10.1002/1097-0142(195801/02)11:1<53::aid-cncr2820110113>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  9. Umpleby H. C., Williamson R. C. The efficacy of agents employed to prevent anastomotic recurrence in colorectal carcinoma. Ann R Coll Surg Engl. 1984 May;66(3):192–194. [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England

RESOURCES